GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NLS Pharmaceutics Ltd (NAS:NLSP) » Definitions » 6-1 Month Momentum %

NLS Pharmaceutics (NLS Pharmaceutics) 6-1 Month Momentum % : -57.19% (As of May. 17, 2024)


View and export this data going back to 2021. Start your Free Trial

What is NLS Pharmaceutics 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-17), NLS Pharmaceutics's 6-1 Month Momentum % is -57.19%.

The industry rank for NLS Pharmaceutics's 6-1 Month Momentum % or its related term are showing as below:

NLSP's 6-1 Month Momentum % is ranked worse than
90.86% of 1531 companies
in the Biotechnology industry
Industry Median: -3.11 vs NLSP: -57.19

Competitive Comparison of NLS Pharmaceutics's 6-1 Month Momentum %

For the Biotechnology subindustry, NLS Pharmaceutics's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NLS Pharmaceutics's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NLS Pharmaceutics's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where NLS Pharmaceutics's 6-1 Month Momentum % falls into.



NLS Pharmaceutics  (NAS:NLSP) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NLS Pharmaceutics  (NAS:NLSP) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


NLS Pharmaceutics 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of NLS Pharmaceutics's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


NLS Pharmaceutics (NLS Pharmaceutics) Business Description

Traded in Other Exchanges
N/A
Address
The Circle 6, Zurich, CHE, 8058
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.